{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:52:25Z","timestamp":1789908745579,"version":"4.0.1"},"reference-count":225,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400005C"],"award-info":[{"award-number":["HHSN272201400005C"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PR17046"],"award-info":[{"award-number":["PR17046"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Influenza virus still represents a considerable threat to global public health, despite the advances in the development and wide use of influenza vaccines. Vaccination with traditional inactivate influenza vaccines (IIV) or live-attenuated influenza vaccines (LAIV) remains the main strategy in the control of annual seasonal epidemics, but it does not offer protection against new influenza viruses with pandemic potential, those that have shifted. Moreover, the continual antigenic drift of seasonal circulating influenza viruses, causing an antigenic mismatch that requires yearly reformulation of seasonal influenza vaccines, seriously compromises vaccine efficacy. Therefore, the quick optimization of vaccine production for seasonal influenza and the development of new vaccine approaches for pandemic viruses is still a challenge for the prevention of influenza infections. Moreover, recent reports have questioned the effectiveness of the current LAIV because of limited protection, mainly against the influenza A virus (IAV) component of the vaccine. Although the reasons for the poor protection efficacy of the LAIV have not yet been elucidated, researchers are encouraged to develop new vaccination approaches that overcome the limitations that are associated with the current LAIV. The discovery and implementation of plasmid-based reverse genetics has been a key advance in the rapid generation of recombinant attenuated influenza viruses that can be used for the development of new and most effective LAIV. In this review, we provide an update regarding the progress that has been made during the last five years in the development of new LAIV and the innovative ways that are being explored as alternatives to the currently licensed LAIV. The safety, immunogenicity, and protection efficacy profile of these new LAIVs reveal their possible implementation in combating influenza infections. However, efforts by vaccine companies and government agencies will be needed for controlled testing and approving, respectively, these new vaccine methodologies for the control of influenza infections.<\/jats:p>","DOI":"10.3390\/v11020190","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T11:26:14Z","timestamp":1550834774000},"page":"190","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Novel Approaches for The Development of Live Attenuated Influenza Vaccines"],"prefix":"10.3390","volume":"11","author":[{"given":"Pilar","family":"Blanco-Lobo","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor","family":"Nogales","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7084-0804","authenticated-orcid":false,"given":"Luis","family":"Mart\u00ednez-Sobrido","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"ref_1","unstructured":"Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., and Martin, M.A. (2007). Orthomyxoviridae: The viruses and their replication. Fields Virology, Lippincott Williams and WIlkins. [5th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza hemagglutinin and neuraminidase membrane glycoproteins","volume":"285","author":"Gamblin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virusres.2009.05.010","article-title":"Influenza virus morphogenesis and budding","volume":"143","author":"Nayak","year":"2009","journal-title":"Virus Res."},{"key":"ref_4","first-page":"153","article-title":"Influenza A: Understanding the viral life cycle","volume":"82","author":"Samji","year":"2009","journal-title":"Yale J. Biol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"ref_6","first-page":"121","article-title":"Orthomyxovirus replication, transcription, and polyadenylation","volume":"283","author":"Neumann","year":"2004","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1073\/pnas.0437772100","article-title":"Selective incorporation of influenza virus RNA segments into virions","volume":"100","author":"Fujii","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.coviro.2012.03.003","article-title":"The role of receptor binding specificity in interspecies transmission of influenza viruses","volume":"2","author":"Imai","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tim.2008.01.008","article-title":"Evolving complexities of influenza virus and its receptors","volume":"16","author":"Nicholls","year":"2008","journal-title":"Trends Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nsmb.1456","article-title":"Viral membrane fusion","volume":"15","author":"Harrison","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/rna.8.2.14513","article-title":"The influenza virus RNA synthesis machine: Advances in its structure and function","volume":"8","author":"Jorba","year":"2011","journal-title":"RNA Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"28411","DOI":"10.1074\/jbc.R110.117531","article-title":"Influenza A virus polymerase: Structural insights into replication and host adaptation mechanisms","volume":"285","author":"Boivin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wise, H.M., Hutchinson, E.C., Jagger, B.W., Stuart, A.D., Kang, Z.H., Robb, N., Schwartzman, L.M., Kash, J.C., Fodor, E., and Firth, A.E. (2012). Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002998"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Paterson, D., and Fodor, E. (2012). Emerging roles for the influenza A virus nuclear export protein (NEP). PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003019"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1128\/JVI.02717-09","article-title":"PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models","volume":"84","author":"Hai","year":"2010","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1126\/science.1222213","article-title":"An overlapping protein-coding region in influenza A virus segment 3 modulates the host response","volume":"337","author":"Jagger","year":"2012","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.febslet.2010.11.017","article-title":"Crucial role of the influenza virus NS2 (NEP) C-terminal domain in M1 binding and nuclear export of vRNP","volume":"585","author":"Shimizu","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1099\/jgv.0.000562","article-title":"Late stages of the influenza A virus replication cycle\u2014A tight interplay between virus and host","volume":"97","author":"Pohl","year":"2016","journal-title":"J. Gen. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1006\/viro.1993.1164","article-title":"Folding and assembly of viral membrane proteins","volume":"193","author":"Doms","year":"1993","journal-title":"Virology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tim.2014.04.001","article-title":"Selective packaging of the influenza A genome and consequences for genetic reassortment","volume":"22","author":"Gerber","year":"2014","journal-title":"Trends Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","article-title":"Influenza virus assembly and budding","volume":"411","author":"Rossman","year":"2011","journal-title":"Virology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.cell.2010.08.029","article-title":"Influenza virus M2 protein mediates ESCRT-independent membrane scission","volume":"142","author":"Rossman","year":"2010","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/303041a0","article-title":"Structure of the catalytic and antigenic sites in influenza virus neuraminidase","volume":"303","author":"Colman","year":"1983","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1743-422X-8-14","article-title":"Identification of critical residues of influenza neuraminidase in viral particle release","volume":"8","author":"Tisoncik","year":"2011","journal-title":"Virol. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"key":"ref_26","unstructured":"World Health Organization (WHO) (2017). WHO Fact Sheet about Seasonal Influenza, WHO."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary Bacterial Infections Associated with Influenza Pandemics","volume":"8","author":"Morris","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Morales, K.F., Paget, J., and Spreeuwenberg, P. (2017). Possible explanations for why some countries were harder hit by the pandemic influenza virus in 2009\u2014A global mortality impact modeling study. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2730-0"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: Measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Dorratoltaj, N., Marathe, A., Lewis, B.L., Swarup, S., Eubank, S.G., and Abbas, K.M. (2017). Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions. PLoS Comput. Biol., 13.","DOI":"10.1371\/journal.pcbi.1005521"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mostafa, A., Abdelwhab, E.M., Mettenleiter, T.C., and Pleschka, S. (2018). Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview. Viruses, 10.","DOI":"10.3390\/v10090497"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"212293","DOI":"10.7573\/dic.212293","article-title":"Influenza vaccination: Key facts for general practitioners in Europe\u2014A synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands","volume":"5","author":"Kassianos","year":"2016","journal-title":"Drugs Context"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.15585\/mmwr.mm6722a4","article-title":"Update: Influenza Activity in the United States During the 2017\u20132018 Season and Composition of the 2018\u20132019 Influenza Vaccine","volume":"67","author":"Garten","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.vaccine.2017.01.018","article-title":"Improving the selection and development of influenza vaccine viruses\u2014Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18\u201320 November 2015","volume":"35","author":"Hampson","year":"2017","journal-title":"Vaccine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2018.00123","article-title":"Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture","volume":"9","author":"Rajao","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"D31","DOI":"10.1016\/j.vaccine.2008.07.078","article-title":"Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses","volume":"26","author":"Russell","year":"2008","journal-title":"Vaccine"},{"key":"ref_38","first-page":"E115","article-title":"History and evolution of influenza control through vaccination: From the first monovalent vaccine to universal vaccines","volume":"57","author":"Barberis","year":"2016","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.79.2.173","article-title":"A Study of Conditions for the Optimum Production of Pr8 Influenza Virus in Chick Embryos","volume":"79","author":"Miller","year":"1944","journal-title":"J. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/CMR.00097-12","article-title":"Traditional and new influenza vaccines","volume":"26","author":"Wong","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0042-6822(76)90481-5","article-title":"Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine","volume":"69","author":"Laver","year":"1976","journal-title":"Virology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","article-title":"FluBlok, a recombinant hemagglutinin influenza vaccine","volume":"2","author":"Cox","year":"2008","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","article-title":"Cold-adapted live influenza vaccine versus inactivated vaccine: Systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis","volume":"20","author":"Beyer","year":"2002","journal-title":"Vaccine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.vaccine.2010.12.049","article-title":"The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons","volume":"29","author":"Katayose","year":"2011","journal-title":"Vaccine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3325\/cmj.2013.54.135","article-title":"Effectiveness of seasonal influenza vaccines in children\u2014A systematic review and meta-analysis","volume":"54","author":"Luksic","year":"2013","journal-title":"Croat Med. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1699-0463.1999.tb01556.x","article-title":"The postvaccination antibody response to influenza virus proteins","volume":"107","author":"Cox","year":"1999","journal-title":"APMIS"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.coi.2018.04.015","article-title":"Influenza vaccines: \u2018tailor-made\u2019 or \u2018one fits all\u2019","volume":"53","author":"Saletti","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.vaccine.2018.02.027","article-title":"Quantitative profiling reveals minor changes of T cell receptor repertoire in response to subunit inactivated influenza vaccine","volume":"36","author":"Sycheva","year":"2018","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Hoft, D.F., Lottenbach, K.R., Blazevic, A., Turan, A., Blevins, T.P., Pacatte, T.P., Yu, Y., Mitchell, M.C., Hoft, S.G., and Belshe, R.B. (2017). Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults. Clin. Vaccine Immunol., 24.","DOI":"10.1128\/CVI.00414-16"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/CVI.00397-07","article-title":"Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children","volume":"15","author":"Forrest","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/infdis\/jiw230","article-title":"Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils","volume":"214","author":"Mohn","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.humimm.2011.03.001","article-title":"Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin","volume":"72","author":"Basha","year":"2011","journal-title":"Hum. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/infdis\/jit207","article-title":"Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets","volume":"208","author":"Cheng","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","article-title":"Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A\/Ann Arbor\/6\/60","volume":"306","author":"Jin","year":"2003","journal-title":"Virology"},{"key":"ref_57","first-page":"426","article-title":"FDA okays live-attenuated nasal spray form of flu vaccine","volume":"69","author":"Cimons","year":"2003","journal-title":"Am. Soc. Microbiol. News"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/213612a0","article-title":"Adaptation and growth characteristics of influenza virus at 25 degrees C","volume":"213","author":"Maassab","year":"1967","journal-title":"Nature"},{"key":"ref_59","first-page":"554","article-title":"Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A\/Ann Arbor\/6\/60 (H2N2)","volume":"167","author":"Cox","year":"1988","journal-title":"Virology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/08828240260066242","article-title":"Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines","volume":"15","author":"Murphy","year":"2002","journal-title":"Viral Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1128\/JVI.02636-14","article-title":"Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine","volume":"89","author":"Cox","year":"2015","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00006454-199912000-00017","article-title":"Intranasal, cold-adapted, live, attenuated influenza vaccine","volume":"18","author":"Abramson","year":"1999","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coviro.2014.02.008","article-title":"Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses","volume":"6","author":"Jin","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1073\/pnas.0708684105","article-title":"Sublingual vaccination with influenza virus protects mice against lethal viral infection","volume":"105","author":"Song","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000351716","article-title":"Olfactory bulb and hypothalamic acute-phase responses to influenza virus: Effects of immunization","volume":"20","author":"Zielinski","year":"2013","journal-title":"Neuroimmunomodulation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1016\/j.vaccine.2012.09.071","article-title":"Development of new generation influenza vaccines: Recipes for success?","volume":"30","author":"Pronker","year":"2012","journal-title":"Vaccine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1086\/502574","article-title":"Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults","volume":"26","author":"Talbot","year":"2005","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist(R); Fluenz): A review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.vaccine.2008.11.093","article-title":"Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials","volume":"27","author":"Rhorer","year":"2009","journal-title":"Vaccine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1586\/14760584.2015.1057573","article-title":"Fluarix quadrivalent vaccine for influenza","volume":"14","author":"Graaf","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.virol.2008.08.010","article-title":"Molecular studies of temperature-sensitive replication of the cold-adapted B\/Ann Arbor\/1\/66, the master donor virus for live attenuated influenza FluMist vaccines","volume":"380","author":"Chen","year":"2008","journal-title":"Virology"},{"key":"ref_72","first-page":"1","article-title":"Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jaci.2014.02.009","article-title":"Influenza vaccination in asthmatic patients","volume":"133","author":"Greenhawt","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Lewnard, J.A., and Cobey, S. (2018). Immune History and Influenza Vaccine Effectiveness. Vaccines, 6.","DOI":"10.3390\/vaccines6020028"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4161\/hv.19917","article-title":"Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: A critical review and re-analysis of 15 meta-analyses","volume":"8","author":"Manzoli","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1146\/annurev.iy.08.040190.003513","article-title":"Structural basis of immune recognition of influenza virus hemagglutinin","volume":"8","author":"Wilson","year":"1990","journal-title":"Annu. Rev. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/S1473-3099(17)30360-2","article-title":"Urgent challenges in implementing live attenuated influenza vaccine","volume":"18","author":"Singanayagam","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1750-2659.2010.00183.x","article-title":"The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults","volume":"5","author":"Ambrose","year":"2011","journal-title":"Influenza Other. Respir. Viruses"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Jefferson, T., Rivetti, A., Di Pietrantonj, C., Demicheli, V., and Ferroni, E. (2008). Vaccines for preventing influenza in healthy children. Cochrane Database Syst. Rev., CD004879.","DOI":"10.1002\/14651858.CD004879.pub3"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e20153279","DOI":"10.1542\/peds.2015-3279","article-title":"Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine","volume":"137","author":"Chung","year":"2016","journal-title":"Pediatrics"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.vaccine.2017.03.085","article-title":"Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014\u20132015 season","volume":"35","author":"McLean","year":"2017","journal-title":"Vaccine"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/cid\/cix869","article-title":"2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States","volume":"66","author":"Poehling","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/infdis\/jix526","article-title":"Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015\u20132016 Season in Canada","volume":"216","author":"Skowronski","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"ofx111","DOI":"10.1093\/ofid\/ofx111","article-title":"Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015-2016: A Systematic Review and Meta-Analysis","volume":"4","author":"Caspard","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1111\/ajt.14511","article-title":"Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2017-18 Influenza Season","volume":"17","author":"Grohskopf","year":"2017","journal-title":"Am. J. Transpl."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"643","DOI":"10.15585\/mmwr.mm6722a5","article-title":"Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4)\u2014United States, 2018\u201319 Influenza Season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/archdischild-2016-312165","article-title":"Live attenuated influenza vaccine (LAIV): Recent effectiveness results from the USA and implications for LAIV programmes elsewhere","volume":"103","author":"Pebody","year":"2018","journal-title":"Arch. Dis. Child."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"30394","DOI":"10.2807\/1560-7917.ES.2016.21.45.30394","article-title":"Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines","volume":"21","author":"Ambrose","year":"2016","journal-title":"Eurosurveill"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"13269","DOI":"10.1128\/JVI.01636-14","article-title":"Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom","volume":"88","author":"Elderfield","year":"2014","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1073\/pnas.1524384113","article-title":"Molecular requirements for a pandemic influenza virus: An acid-stable hemagglutinin protein","volume":"113","author":"Russier","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"12374","DOI":"10.1128\/JVI.01107-14","article-title":"The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines","volume":"88","author":"Vogel","year":"2014","journal-title":"J. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/infdis\/jiv260","article-title":"Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model","volume":"212","author":"Laurie","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1016\/j.vaccine.2016.08.079","article-title":"Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States","volume":"34","author":"Caspard","year":"2016","journal-title":"Vaccine"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Gould, P.S., Easton, A.J., and Dimmock, N.J. (2017). Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA. Viruses, 9.","DOI":"10.3390\/v9100269"},{"key":"ref_97","first-page":"1","article-title":"General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Kroger","year":"2011","journal-title":"MMWR Recomm. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/vaccines3020373","article-title":"Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines","volume":"3","author":"Sridhar","year":"2015","journal-title":"Vaccines"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Nogales, A., Rodriguez, L., Chauche, C., Huang, K., Reilly, E.C., Topham, D.J., Murcia, P.R., Parrish, C.R., and Martinez-Sobrido, L. (2017). Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine. J. Virol., 91.","DOI":"10.1128\/JVI.02211-16"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/j.vaccine.2011.02.079","article-title":"WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: Supporting developing country production capacity through technology transfer","volume":"29","author":"Friede","year":"2011","journal-title":"Vaccine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1016\/j.vaccine.2015.06.061","article-title":"Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptance","volume":"33","author":"Burgess","year":"2015","journal-title":"Vaccine"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.1128\/JVI.01440-14","article-title":"Influenza A and B virus intertypic reassortment through compatible viral packaging signals","volume":"88","author":"Baker","year":"2014","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.026187-0","article-title":"Molecular studies of influenza B virus in the reverse genetics era","volume":"92","author":"Jackson","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Martinez-Sobrido, L., and Garcia-Sastre, A. (2010). Generation of recombinant influenza virus from plasmid DNA. J. Vis. Exp.","DOI":"10.3791\/2057"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1750-2659.2012.00392.x","article-title":"Many ways to make an influenza virus\u2014Review of influenza virus reverse genetics methods","volume":"7","author":"Engelhardt","year":"2013","journal-title":"Influenza Other. Respir. Viruses"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1128\/JVI.01433-09","article-title":"Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies","volume":"84","author":"Cadagan","year":"2010","journal-title":"J. Virol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virusres.2015.07.013","article-title":"Development and applications of single-cycle infectious influenza A virus (sciIAV)","volume":"216","author":"Nogales","year":"2016","journal-title":"Virus Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virol.2014.12.006","article-title":"Replication-competent influenza A viruses expressing a red fluorescent protein","volume":"476","author":"Nogales","year":"2015","journal-title":"Virology"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Breen, M., Nogales, A., Baker, S.F., and Martinez-Sobrido, L. (2016). Replication-Competent Influenza A Viruses Expressing Reporter Genes. Viruses, 8.","DOI":"10.3390\/v8070179"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Breen, M., Nogales, A., Baker, S.F., Perez, D.R., and Martinez-Sobrido, L. (2016). Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147723"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1016\/j.vaccine.2017.06.060","article-title":"A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses","volume":"35","author":"Rodriguez","year":"2017","journal-title":"Vaccine"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.virol.2017.01.020","article-title":"A live-attenuated influenza vaccine for H3N2 canine influenza virus","volume":"504","author":"Rodriguez","year":"2017","journal-title":"Virology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2018.01.005","article-title":"Development of a novel equine influenza virus live-attenuated vaccine","volume":"516","author":"Rodriguez","year":"2018","journal-title":"Virology"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Nogales, A., and Martinez-Sobrido, L. (2016). Reverse Genetics Approaches for the Development of Influenza Vaccines. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010020"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/viro.1999.0140","article-title":"\u201cAmbisense\u201d approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template","volume":"267","author":"Hoffmann","year":"2000","journal-title":"Virology"},{"key":"ref_117","unstructured":"World Health Organization (WHO) (2005). WHO Guidance on Development of Influenza Vaccine Reference Viruses by Reverse Genetics, WHO."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1586\/erv.11.82","article-title":"The future of cell culture-based influenza vaccine production","volume":"10","author":"Perdue","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/21645515.2015.1016666","article-title":"Cell culture-based influenza vaccines: A necessary and indispensable investment for the future","volume":"11","author":"Hegde","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Manini, I., Trombetta, C.M., Lazzeri, G., Pozzi, T., Rossi, S., and Montomoli, E. (2017). Egg-Independent Influenza Vaccines and Vaccine Candidates. Vaccines, 5.","DOI":"10.3390\/vaccines5030018"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/erv.09.19","article-title":"Vero cell platform in vaccine production: Moving towards cell culture-based viral vaccines","volume":"8","author":"Barrett","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jviromet.2013.04.020","article-title":"Comparison of initial feasibility of host cell lines for viral vaccine production","volume":"193","author":"Vlecken","year":"2013","journal-title":"J. Virol. Methods"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Harding, A.T., and Heaton, N.S. (2018). Efforts to Improve the Seasonal Influenza Vaccine. Vaccines, 6.","DOI":"10.3390\/vaccines6020019"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41541-018-0079-z","article-title":"Cell culture-derived influenza vaccines in the severe 2017\u20132018 epidemic season: A step towards improved influenza vaccine effectiveness","volume":"3","author":"Barr","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Fulvini, A.A., Ramanunninair, M., Le, J., Pokorny, B.A., Arroyo, J.M., Silverman, J., Devis, R., and Bucher, D. (2011). Gene constellation of influenza A virus reassortants with high growth phenotype prepared as seed candidates for vaccine production. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020823"},{"key":"ref_126","first-page":"151","article-title":"Inactivated and adjuvanted influenza vaccines","volume":"386","author":"Rappuoli","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/j.vaccine.2004.08.054","article-title":"Generation of influenza vaccine viruses on Vero cells by reverse genetics: An H5N1 candidate vaccine strain produced under a quality system","volume":"23","author":"Nicolson","year":"2005","journal-title":"Vaccine"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/v2020532","article-title":"Developing vaccines to combat pandemic influenza","volume":"2","author":"Robertson","year":"2010","journal-title":"Viruses"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nm0415-297","article-title":"After flu vaccine mismatch, calls for delayed selection intensify","volume":"21","author":"Marill","year":"2015","journal-title":"Nat. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1099\/vir.0.2008\/004606-0","article-title":"The multifunctional NS1 protein of influenza A viruses","volume":"89","author":"Hale","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1099\/vir.0.032060-0","article-title":"The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways","volume":"92","author":"Tisoncik","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_132","first-page":"654","article-title":"Networks of Host Factors that Interact with NS1 Protein of Influenza A Virus","volume":"7","author":"Zhou","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fimmu.2018.00743","article-title":"Influenza Virus: A Master Tactician in Innate Immune Evasion and Novel Therapeutic Interventions","volume":"9","author":"Hsu","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Chauche, C., Nogales, A., Zhu, H., Goldfarb, D., Ahmad Shanizza, A.I., Gu, Q., Parrish, C.R., Martinez-Sobrido, L., Marshall, J.F., and Murcia, P.R. (2018). Mammalian Adaptation of an Avian Influenza A Virus Involves Stepwise Changes in NS1. J. Virol., 92.","DOI":"10.1128\/JVI.01875-17"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Clark, A.M., Nogales, A., Martinez-Sobrido, L., Topham, D.J., and DeDiego, M.L. (2017). Functional Evolution of Influenza Virus NS1 Protein in Currently Circulating Human 2009 Pandemic H1N1 Viruses. J. Virol., 91.","DOI":"10.1128\/JVI.00721-17"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1128\/JVI.01039-16","article-title":"NS1 Protein Mutation I64T Affects Interferon Responses and Virulence of Circulating H3N2 Human Influenza A Viruses","volume":"90","author":"DeDiego","year":"2016","journal-title":"J. Virol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Nogales, A., Chauche, C., DeDiego, M.L., Topham, D.J., Parrish, C.R., Murcia, P.R., and Martinez-Sobrido, L. (2017). The K186E Amino Acid Substitution in the Canine Influenza Virus H3N8 NS1 Protein Restores Its Ability to Inhibit Host Gene Expression. J. Virol., 91.","DOI":"10.1128\/JVI.00877-17"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2016.10.008","article-title":"Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines","volume":"500","author":"Nogales","year":"2017","journal-title":"Virology"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Nogales, A., Martinez-Sobrido, L., Chiem, K., Topham, D.J., and DeDiego, M.L. (2018). Functional Evolution of the 2009 Pandemic H1n1 Influenza Ns1 and Pa in Humans. J. Virol., 92.","DOI":"10.1128\/JVI.01206-18"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Nogales, A., Martinez-Sobrido, L., Topham, D.J., and DeDiego, M.L. (2017). NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses. J. Virol., 91.","DOI":"10.1128\/JVI.01930-16"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Nogales, A., Rodriguez, L., DeDiego, M.L., Topham, D.J., and Martinez-Sobrido, L. (2017). Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus. J. Virol., 91.","DOI":"10.1128\/JVI.00720-17"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/viro.1998.9508","article-title":"Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems","volume":"252","author":"Egorov","year":"1998","journal-title":"Virology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1099\/vir.0.80991-0","article-title":"Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins","volume":"86","author":"Falcon","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fcimb.2018.00127","article-title":"A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus","volume":"8","author":"Chen","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1073\/pnas.76.10.4908","article-title":"Segment 8 of the influenza virus genome is unique in coding for two polypeptides","volume":"76","author":"Lamb","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1128\/JVI.79.13.8431-8439.2005","article-title":"Attenuation of equine influenza viruses through truncations of the NS1 protein","volume":"79","author":"Quinlivan","year":"2005","journal-title":"J. Virol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1128\/JVI.00787-06","article-title":"Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine","volume":"80","author":"Richt","year":"2006","journal-title":"J. Virol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1128\/JVI.79.12.7535-7543.2005","article-title":"Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs","volume":"79","author":"Solorzano","year":"2005","journal-title":"J. Virol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1016\/j.vaccine.2007.09.019","article-title":"Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine","volume":"25","author":"Vincent","year":"2007","journal-title":"Vaccine"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2011.10.098","article-title":"Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs","volume":"30","author":"Kappes","year":"2012","journal-title":"Vaccine"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.01920-08","article-title":"Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza","volume":"83","author":"Steel","year":"2009","journal-title":"J. Virol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.vaccine.2008.05.001","article-title":"Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00705-015-2442-y","article-title":"Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene","volume":"160","author":"Choi","year":"2015","journal-title":"Arch. Virol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Jang, H., Ngunjiri, J.M., and Lee, C.W. (2016). Association between Interferon Response and Protective Efficacy of NS1-Truncated Mutants as Influenza Vaccine Candidates in Chickens. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156603"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Jang, H., Elaish, M., Kc, M., Abundo, M.C., Ghorbani, A., Ngunjiri, J.M., and Lee, C.W. (2018). Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195285"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"11817","DOI":"10.1128\/JVI.00590-07","article-title":"Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus","volume":"81","author":"Baskin","year":"2007","journal-title":"J. Virol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.1128\/JVI.01131-12","article-title":"NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge","volume":"86","author":"Pica","year":"2012","journal-title":"J. Virol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1086\/649428","article-title":"A novel type of influenza vaccine: Safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1","volume":"201","author":"Wacheck","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1073\/pnas.070525997","article-title":"Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach","volume":"97","author":"Talon","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.vaccine.2013.10.061","article-title":"Phase I\/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1","volume":"31","author":"Mossler","year":"2013","journal-title":"Vaccine"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"12951","DOI":"10.1128\/JVI.76.24.12951-12962.2002","article-title":"Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains","volume":"76","author":"Wang","year":"2002","journal-title":"J. Virol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0952-7915(02)00354-0","article-title":"Links between innate and adaptive immunity via type I interferon","volume":"14","author":"Tough","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni978","article-title":"Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon","volume":"4","author":"Etchart","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2899","article-title":"Synonymous but not the same: The causes and consequences of codon bias","volume":"12","author":"Plotkin","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4682-5-16","article-title":"Does codon bias have an evolutionary origin?","volume":"5","author":"Biro","year":"2008","journal-title":"Biol. Med. Model."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.genet.42.110807.091442","article-title":"Selection on codon bias","volume":"42","author":"Hershberg","year":"2008","journal-title":"Annu. Rev. Genet."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Kumar, N., Bera, B.C., Greenbaum, B.D., Bhatia, S., Sood, R., Selvaraj, P., Anand, T., Tripathi, B.N., and Virmani, N. (2016). Revelation of Influencing Factors in Overall Codon Usage Bias of Equine Influenza Viruses. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154376"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Wong, E.H., Smith, D.K., Rabadan, R., Peiris, M., and Poon, L.L. (2010). Codon usage bias and the evolution of influenza A viruses. Codon Usage Biases of Influenza Virus. BMC Evol. Biol., 10.","DOI":"10.1186\/1471-2148-10-253"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1743-422X-9-263","article-title":"Pandemic influenza A virus codon usage revisited: Biases, adaptation and implications for vaccine strain development","volume":"9","author":"Goni","year":"2012","journal-title":"Virol. J."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12250-010-3123-3","article-title":"Analysis of synonymous codon usage bias in 09H1N1","volume":"25","author":"Li","year":"2010","journal-title":"Virol. Sin."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.biosystems.2005.03.002","article-title":"Analysis of synonymous codon usage in H5N1 virus and other influenza A viruses","volume":"81","author":"Zhou","year":"2005","journal-title":"Biosystems"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1702(02)00309-X","article-title":"The extent of codon usage bias in human RNA viruses and its evolutionary origin","volume":"92","author":"Jenkins","year":"2003","journal-title":"Virus Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nbt.1636","article-title":"Live attenuated influenza virus vaccines by computer-aided rational design","volume":"28","author":"Mueller","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"9481","DOI":"10.1073\/pnas.1307473110","article-title":"Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/fvl.15.31","article-title":"Downregulating viral gene expression: Codon usage bias manipulation for the generation of novel influenza A virus vaccines","volume":"10","author":"Baker","year":"2015","journal-title":"Future Virol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1128\/JVI.01443-15","article-title":"Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias","volume":"89","author":"Fan","year":"2015","journal-title":"J. Virol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.vaccine.2015.11.054","article-title":"Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets","volume":"34","author":"Broadbent","year":"2016","journal-title":"Vaccine"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1128\/JVI.01565-14","article-title":"Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development","volume":"88","author":"Nogales","year":"2014","journal-title":"J. Virol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1534\/g3.117.041020","article-title":"Reduced Protein Expression in a Virus Attenuated by Codon Deoptimization","volume":"7","author":"Jack","year":"2017","journal-title":"G3 (Bethesda)"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1128\/JVI.00738-06","article-title":"Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity","volume":"80","author":"Mueller","year":"2006","journal-title":"J. Virol."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Sutejo, R., Yeo, D.S., Myaing, M.Z., Hui, C., Xia, J., Ko, D., Cheung, P.C., Tan, B.H., and Sugrue, R.J. (2012). Activation of type I and III interferon signalling pathways occurs in lung epithelial cells infected with low pathogenic avian influenza viruses. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033732"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.1155761","article-title":"Virus attenuation by genome-scale changes in codon pair bias","volume":"320","author":"Coleman","year":"2008","journal-title":"Science"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Moura, G., Pinheiro, M., Arrais, J., Gomes, A.C., Carreto, L., Freitas, A., Oliveira, J.L., and Santos, M.A. (2007). Large scale comparative codon-pair context analysis unveils general rules that fine-tune evolution of mRNA primary structure. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000847"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Biggerstaff, M., Cauchemez, S., Reed, C., Gambhir, M., and Finelli, L. (2014). Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: A systematic review of the literature. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-480"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1017\/S0950268818001292","article-title":"Review analysis and impact of co-circulating H5N1 and H9N2 avian influenza viruses in Bangladesh","volume":"146","author":"Parvin","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1128\/JVI.02490-12","article-title":"Influenza viruses with rearranged genomes as live-attenuated vaccines","volume":"87","author":"Pena","year":"2013","journal-title":"J. Virol."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Harding, A.T., Heaton, B.E., Dumm, R.E., and Heaton, N.S. (2017). Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs. MBio, 8.","DOI":"10.1128\/mBio.00669-17"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1128\/JVI.79.11.6763-6771.2005","article-title":"Improvement of influenza A\/Fujian\/411\/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics","volume":"79","author":"Lu","year":"2005","journal-title":"J. Virol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1128\/JVI.00410-16","article-title":"Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines","volume":"90","author":"Nogales","year":"2016","journal-title":"J. Virol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.virol.2005.09.020","article-title":"Replication-defective viruses as vaccines and vaccine vectors","volume":"344","author":"Dudek","year":"2006","journal-title":"Virology"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.sbi.2015.03.002","article-title":"Stable mammalian producer cell lines for structural biology","volume":"32","author":"Bussow","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/biot.201200364","article-title":"Evaluating the influence of selection markers on obtaining selected pools and stable cell lines in human cells","volume":"8","author":"Lanza","year":"2013","journal-title":"Biotechnol. J."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/intimm\/9.2.249","article-title":"A major T cell determinant from the influenza virus hemagglutinin (HA) can be a cryptic self peptide in HA transgenic mice","volume":"9","author":"Shih","year":"1997","journal-title":"Int. Immunol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1128\/JVI.01204-12","article-title":"Competitive incorporation of homologous gene segments of influenza A virus into virions","volume":"86","author":"Inagaki","year":"2012","journal-title":"J. Virol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"9727","DOI":"10.1128\/JVI.01144-07","article-title":"Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions","volume":"81","author":"Marsh","year":"2007","journal-title":"J. Virol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1099\/vir.0.037648-0","article-title":"Replication-incompetent influenza A viruses that stably express a foreign gene","volume":"92","author":"Ozawa","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/cmdc.201200453","article-title":"Identification of small molecules that interfere with H1N1 influenza A viral replication","volume":"7","author":"Bottini","year":"2012","journal-title":"ChemMedChem"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"Bloom","year":"2010","journal-title":"Science"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Bloom, J.D., Nayak, J.S., and Baltimore, D. (2011). A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022201"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1128\/JVI.00012-15","article-title":"Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice","volume":"89","author":"Hooper","year":"2015","journal-title":"J. Virol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1128\/JVI.06232-11","article-title":"A replication-incompetent PB2-knockout influenza A virus vaccine vector","volume":"86","author":"Victor","year":"2012","journal-title":"J. Virol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1128\/JVI.00076-13","article-title":"A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges","volume":"87","author":"Uraki","year":"2013","journal-title":"J. Virol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1016\/j.vaccine.2013.10.029","article-title":"A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine","volume":"31","author":"Kobayashi","year":"2013","journal-title":"Vaccine"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00705-013-1932-z","article-title":"A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus","volume":"159","author":"Fonseca","year":"2014","journal-title":"Arch. Virol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1128\/JVI.01081-13","article-title":"Protection against lethal influenza with a viral mimic","volume":"87","author":"Baker","year":"2013","journal-title":"J. Virol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"12006","DOI":"10.1128\/JVI.01847-14","article-title":"Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus","volume":"88","author":"Guo","year":"2014","journal-title":"J. Virol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"13397","DOI":"10.1128\/JVI.01820-12","article-title":"Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity","volume":"86","author":"Powell","year":"2012","journal-title":"J. Virol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1016\/j.vaccine.2012.07.059","article-title":"A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine","volume":"30","author":"Katsura","year":"2012","journal-title":"Vaccine"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"13410","DOI":"10.1128\/JVI.01205-14","article-title":"A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection","volume":"88","author":"Katsura","year":"2014","journal-title":"J. Virol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1128\/JVI.78.6.3083-3088.2004","article-title":"Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine","volume":"78","author":"Shinya","year":"2004","journal-title":"J. Virol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1128\/JVI.01348-13","article-title":"An eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs","volume":"87","author":"Masic","year":"2013","journal-title":"J. Virol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1016\/j.vaccine.2014.04.065","article-title":"Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection","volume":"32","author":"Pyo","year":"2014","journal-title":"Vaccine"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1016\/j.vaccine.2017.06.039","article-title":"M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza","volume":"35","author":"Hatta","year":"2017","journal-title":"Vaccine"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1016\/j.vaccine.2016.08.061","article-title":"M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice","volume":"34","author":"Sarawar","year":"2016","journal-title":"Vaccine"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1016\/j.vaccine.2011.02.082","article-title":"Use of GFP-expressing influenza viruses for the detection of influenza virus A\/H5N1 neutralizing antibodies","volume":"29","author":"Rimmelzwaan","year":"2011","journal-title":"Vaccine"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1016\/j.vaccine.2015.05.049","article-title":"Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA)","volume":"33","author":"Baker","year":"2015","journal-title":"Vaccine"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0092-8674(00)81771-7","article-title":"Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation","volume":"95","author":"Chen","year":"1998","journal-title":"Cell"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/138955751410141020150822","article-title":"Viral M2 ion channel protein: A promising target for anti-influenza drug discovery","volume":"14","author":"Moorthy","year":"2014","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1128\/JVI.00450-09","article-title":"Influenza A virus lacking M2 protein as a live attenuated vaccine","volume":"83","author":"Watanabe","year":"2009","journal-title":"J. Virol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/JVI.01899-07","article-title":"Novel approach to the development of effective H5N1 influenza A virus vaccines: Use of M2 cytoplasmic tail mutants","volume":"82","author":"Watanabe","year":"2008","journal-title":"J. Virol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.vaccine.2011.01.023","article-title":"An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus","volume":"29","author":"Hatta","year":"2011","journal-title":"Vaccine"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1126\/science.aah5869","article-title":"Generation of influenza A viruses as live but replication-incompetent virus vaccines","volume":"354","author":"Si","year":"2016","journal-title":"Science"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0022-2836(05)80258-X","article-title":"Construction of Escherichia coli amber suppressor tRNA genes. III. Determination of tRNA specificity","volume":"213","author":"Normanly","year":"1990","journal-title":"J. Mol. Biol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12985-017-0918-y","article-title":"Towards a universal influenza vaccine: Different approaches for one goal","volume":"15","author":"Sautto","year":"2018","journal-title":"Virol. J."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/2\/190\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:34:10Z","timestamp":1760186050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/2\/190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":225,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["v11020190"],"URL":"https:\/\/doi.org\/10.3390\/v11020190","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]}}}